image credit: Unsplash

Sanofi and Translate take first mRNA flu vaccine into clinic

June 22, 2021


Enthusiasm for mRNA vaccines is riding high amid the successful rollout of COVID-19 shots from Pfizer/BioNTech and Moderna, and attention is now turning toe the possibility of using the approach to tackle other infectious diseases.

Influenza is a likely candidate, as the virus changes rapidly, which can make it hard to anticipate the right strains to target ahead of the annual flu season. mRNA vaccines can be developed very quickly and – if the results of COVID-19 vaccine trials are applicable – could offer a more potent option to conventional flu shots.

Read More on Pharmaphorum